Hospice News
MARCH 14, 2025
The Texas-headquartered company provides hospice, home health and rehabilitation services. billion in 2022, Medicare (MedPAC) reported. in 2022, the National Alliance for Care at Home reported. Details in the data trends The U.S. This is a rise from Medicare hospice expenditures that reached $23.7
Hospice News
OCTOBER 14, 2022
Centers for Medicare & Medicaid Services (CMS) allowed Medicare Advantage (MA) plans to offer non-skilled home care services as a supplemental benefit. In 2022, close to 15% of all MA plans – about 1,000 in total – offer in-home support services, according to Washington, D.C.-based As of 2019, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
OCTOBER 27, 2022
Medicare rate increase for 2022 was offset by the return of sequestration, and cost-per-visit increased 62 cents due to wage inflation and sign-on and retention bonuses. Clinical capacity is going to be our secret for success on both lines of business over the coming years.”. Other factors also impacted hospice revenue. Much of the 2.7%
Hospice News
NOVEMBER 23, 2022
31, 2022. “On The company has been aggressive on acquisitions for the past two years but paused in early 2022 to integrate its most recently acquired assets and accumulate capital. But executives indicated that they would be back on the hunt during the second half of 2022 and into 2023.
Hospice News
AUGUST 23, 2024
The organization planned to begin construction in 2022 and open by the end of 2023. Inpatient hospice services will still be available at the SNF upon its yet-to-be-determined reopening in addition to short-term rehabilitation services. The health system anticipates the location to remain closed until the end of 2025.
Hospice News
DECEMBER 5, 2023
AREX has been an Enhabit investor since it spun off from Encompass Health Corporation’s (NYSE: EHC) home health and hospice segments in July 2022. AREX Capital Management in June began urging the Dallas-based home health and hospice’s board of directors to explore strategic alternatives, in part driven by these two massive deals.
Expert insights. Personalized for you.
180 
Let's personalize your content